产品: TBK1 抗体
货号: DF7026
描述: Rabbit polyclonal antibody to TBK1
应用: WB IHC IF/ICC
文献验证: WB
反应: Human, Mouse, Rat
预测: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
蛋白号: Q9UHD2
RRID: AB_2838982

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
TBK1 Antibody detects endogenous levels of total TBK1.
RRID:
AB_2838982
引用格式: Affinity Biosciences Cat# DF7026, RRID:AB_2838982.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

EC 2.7.11.1; FLJ11330; FTDALS4; NAK; NF kappa B activating kinase; NF kB activating kinase; NF-kappa-B-activating kinase; Serine/threonine protein kinase TBK 1; Serine/threonine protein kinase TBK1; Serine/threonine-protein kinase TBK1; T2K; TANK binding kinase 1; TANK-binding kinase 1; TBK 1; Tbk1; TBK1_HUMAN;

抗原和靶标

免疫原:

A synthesized peptide derived from human TBK1, corresponding to a region within the internal amino acids.

基因/基因ID:
描述:
The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors.

研究领域

· Environmental Information Processing > Signal transduction > Ras signaling pathway.   (View pathway)

· Human Diseases > Infectious diseases: Viral > Hepatitis C.

· Human Diseases > Infectious diseases: Viral > Hepatitis B.

· Human Diseases > Infectious diseases: Viral > Measles.

· Human Diseases > Infectious diseases: Viral > Influenza A.

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.

· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.

· Organismal Systems > Immune system > Toll-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > NOD-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > RIG-I-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Cytosolic DNA-sensing pathway.   (View pathway)

· Organismal Systems > Immune system > IL-17 signaling pathway.   (View pathway)

文献引用

1). A Hybrid Nanoadjuvant Simultaneously Depresses PD-L1/TGF-β1 and Activates cGAS-STING Pathway to Overcome Radio-Immunotherapy Resistance. Advanced materials (Deerfield Beach, Fla.), 2024 (PubMed: 38229577) [IF=27.4]

2). Proteogenomic characterization of MiT family translocation renal cell carcinoma. Nature communications, 2022 (PubMed: 36470859) [IF=16.6]

3). Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics. Acta Pharmaceutica Sinica B, 2022 (PubMed: 35127377) [IF=14.7]

Application: WB    Species: Human    Sample: THP1 cells

Figure 6 SHP2 negatively regulates type I interferon signaling via STING–TBK1–IRF3 pathway. PMA-differentiated THP1 cells were simulated by 2′,3′-cGAMP (0.5 μg/mL) for 2, 4, and 6 h or simulated by 2′,3′-cGAMP for 4 h after incubation with or without the indicated concentrations of SHP099 for 1 h. (A, B) Relative mRNA expression of CXCL10, IFIT1, IFIT2 and ISG15 was examined by qPCR. (C, D) IFN-β in the supernatant were detected by ELISA. Primarily cultured BMDMs from WT and Ptpn11lyz2−/– were simulated by CMA (500 μg/mL) for 2, 4, or 6 h as indicated. (E) Relative mRNA expression of Cxcl10, Ifit1, Ifit2 and Isg15 were examined by qPCR. (F) IFN-β in the supernatant were detected by ELISA. Data represent mean ± SEM; (A) and (C): n = 5; (B, D–F): n = 3; ∗P < 0.05. (G) Protein levels of p-TBK1, TBK1, p-IRF3, IRF3, STING and SHP2 were analyzed by Western blot. β-Actin was shown as loading control. (H) Primarily cultured BMDMs from WT and Ptpn11lyz2−/– were simulated by CMA (500 μg/mL) for 30 and 60 min as indicated. The subcellular localization of IRF3 (shown in green) was analyzed via confocal microscopy. Cell nuclei were visualized by DAPI (blue). Scale bar, 10 μm. (I) Percentage of the cells with IRF3 nuclear localization from Panel H. Data are shown as the mean ± SEM of five fields of view, ∗P < 0.05.

4). Ginsenoside Rd promotes omentin secretion in adipose through TBK1-AMPK to improve mitochondrial biogenesis via WNT5A/Ca2+ pathways in heart failure. Redox biology, 2023 (PubMed: 36652744) [IF=10.7]

Application: WB    Species: Mouse    Sample: 3T3-L1 cells

Fig. 3 TBK1-AMPK signaling pathway modulated the omentin expression in LPS-induced 3T3-L1 adipocytes. Differentiated 3T3-L1 cells were treated with or without AICAR (500 μM) for 2 h, followed by stimulation with LPS (1 μg/mL) for 24 h. (A) Expression of the ratio of p-TBK1 to TBK1 was measured by Western blot in differentiated 3T3-L1 cells (n = 5). (B) Expression of the ratio of p-AMPK to AMPK was measured by Western blot in differentiated 3T3-L1 cells (n = 5). Quantitative real-time PCR analysis of (C) TNF-α and (D) omentin mRNA expression. (E) The omentin fluorescence intensity was detected by immunofluorescence (Scale bar = 20 μm) and (F) the expression of omentin was detected by Western blot in differentiated 3T3-L1 cells (n = 5). Differentiated 3T3-L1 cells were treated with or without compound C (CC; 10 μM) for 2 h, followed by stimulation with LPS (1 μg/mL) for 24 h. Quantitative real-time PCR analysis of (G) TNF-α, (H) omentin mRNA expression. (I) The omentin fluorescence intensity was detected by immunofluorescence (Scale bar = 20 μm) and (J) the expression of omentin protein was detected by Western blot in differentiated 3T3-L1 cells (n = 5). Differentiated 3T3-L1 cells were treated with or without amlexanox (Amx; 500 μM) for 2 h, followed by stimulation with LPS (1 μg/mL) for 24 h. Quantitative real-time PCR analysis of (K) TNF-α and (L) omentin mRNA expression in differentiated 3T3-L1 cells (n = 5). (M) The omentin fluorescence intensity was detected by immunofluorescence (n = 5). Scale bar = 20 μm. (N) The expression of omentin and (O) the ratio of p-AMPK to AMPK were detected by Western blot in differentiated 3T3-L1 cells (n = 5). (P) The effects of TBK1-siRNA on omentin mRNA expression were detected by quantitative real-time PCR analysis. Values are expressed as the means ± SD. One-way ANOVA was followed by the Dunnett's post hoc test. #P < 0.05, ##P < 0.01, ###P < 0.001 LPS vs. Control; *P < 0.05, **P < 0.01, ***P < 0.001 Rd + LPS or AICAR + LPS or CC + LPS or Amx + LPS vs. LPS.

5). Novel intravenous formulation for radiosensitization in osteosarcoma treatment. Materials today. Bio, 2025 (PubMed: 40206141) [IF=8.7]

6). TBK1 Facilitates GLUT1-Dependent Glucose Consumption by suppressing mTORC1 Signaling in Colorectal Cancer Progression. International Journal of Biological Sciences, 2023 (PubMed: 35637944) [IF=8.2]

7). Commensal cow Roseburia reduces gut-dysbiosis-induced mastitis through inhibiting bacterial translocation by producing butyrate in mice. Cell Reports, 2022 (PubMed: 36417859) [IF=7.5]

8). Swine acute diarrhoea syndrome coronavirus (SADS-CoV) Nsp5 antagonizes type I interferon signaling by cleaving DCP1A. Frontiers in Immunology, 2023 (PubMed: 37283741) [IF=5.7]

9). Honokiol ameliorates silica-induced lung fibrosis by inhibiting macrophage pyroptosis via modulating cGAS/STING signaling. International immunopharmacology, 2024 (PubMed: 39681061) [IF=5.6]

10). Patchouli alcohol alleviates metabolic dysfunction-associated steatohepatitis via inhibiting mitochondria-associated endoplasmic reticulum membrane disruption-induced hepatic steatosis and inflammation in rats. International immunopharmacology, 2024 (PubMed: 38971107) [IF=4.8]

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.